(Q28341314)

English

Ifosfamide and mesna in the treatment of malignant disease mesna as urothelial protector

scientific article (publication date: July 1989)

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Ifosfamide and mesna in the treatment of malignant disease mesna as urothelial protector (English)

0 references

1 reference

1 reference

C I Falkson

1

0 references

H C Falkson

series ordinal

2

0 references

G Falkson

series ordinal

3

0 references

language of work or name

English

0 references

publication date

July 1989

0 references

published in

Investigational New Drugs

0 references

volume

7

0 references

page(s)

261-7

0 references

issue

2-3

0 references

cites work

The control of ifosfamide-induced hematuria with N-acetylcysteine in patients with advanced carcinoma of the lung

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2507474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II clinical trial of isophosphamide (NSC-109724) in patients with advances breast cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2507474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ifosfamide chemotherapy for pancreatic carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2507474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ifosfamide in experimental tumor systems

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2507474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mesna--a short review

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2507474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protection against the toxicity of alkylating agents by thiols: The mechanism of protection and its relevance to cancer chemotherapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2507474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The comparative pharmacology of cyclophosphamide and ifosfamide

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2507474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Studies on the toxicity of nitromin; interference of cystein upon nitromin toxicity]

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2507474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of isophosphamide-induced urothelial toxicity with 2-mercaptoethane sulphonate sodium (mesnum) in patients with advanced carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2507474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ifosfamide in advanced pancreatic cancer. A 5-year experience

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2507474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical trial of isophosphamide (NSC-109724)--results and side effects

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2507474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unexpected toxicity in patients treated with iphosphamide

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2507474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Further experience with isophosphamide

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2507474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mesnum as a protector against kidney and bladder toxicity with high-dose ifosfamide treatment

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2507474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention--I. Experimental studies on the urotoxicity of alkylating compounds

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2507474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I clinical trial of isophosphamide (NSC-109724)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2507474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/BF00170871

0 references

Dimensions Publication ID

1034861718

0 references

PubMed ID

2507474

0 references

Springer Nature article ID

10.1007/bf00170871

0 references

(Q28341314)

Ifosfamide and mesna in the treatment of malignant disease mesna as urothelial protector

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)